SCHEMBL9190299

SCHEMBL9190299

CCOC(=O)C(CC=C(C)C)C(=O)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
LMNA P02545 2/20 0.42
HSD17B10 Q99714 1/20 0.42
FNTA P49354 1/20 0.40
FNTB P49356 1/20 0.40
GLO1 Q04760 1/20 0.38
GRIK1 P39086 1/20 0.36
GRIK2 Q13002 1/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP2C9 P11712 1/20 0.36
ALOX15 P16050 2/20 0.36
MGAM O43451 1/20 0.36
GAA P10253 1/20 0.36
SI P14410 1/20 0.36
MGAM2 Q2M2H8 1/20 0.36
SOAT1 P35610 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7694807 0.92 LMNA (0.39) ALDH1A1LMNAHSD17B10FNTAFNTB
SCHEMBL11774659 0.88 CYP2D6 (0.40) ALDH1A1LMNAHSD17B10FNTAFNTB
SCHEMBL11130468 0.87 GLO1 (0.40) ALDH1A1LMNAHSD17B10FNTAFNTB
SCHEMBL10837285 0.81 ALDH1A1 (0.41) ALDH1A1LMNAHSD17B10GLO1GRIK1
SCHEMBL4740790 0.80 FNTA (0.41) ALDH1A1FNTAFNTBGRIK1GRIK2
SCHEMBL8990247 0.79 ALDH1A1 (0.43) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL5142671 0.79 GRIK1 (0.46) ALDH1A1LMNAHSD17B10GLO1GRIK1
SCHEMBL28127614 0.79 ALDH1A1 (0.39) ALDH1A1LMNAHSD17B10GLO1GRIK1
SCHEMBL9040524 0.77 ALDH1A1 (0.42) ALDH1A1LMNAHSD17B10GLO1CYP2D6
SCHEMBL10963096 0.76 MEN1 (0.38) ALDH1A1LMNAHSD17B10FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9737504-B2 Dihydroorotic and acid dehydrogenase inhibitor INSTITUTE OF MITOCHONDRIA SCIENCE, INC. (JP) 2017-08-22 US disclosed
US-9737504-B2 Dihydroorotic and acid dehydrogenase inhibitor INSTITUTE OF MITOCHONDRIA SCIENCE, INC. (JP) 2017-08-22 US disclosed
US-20160296494-A1 DIHYDROOROTIC AND ACID DEHYDROGENASE INHIBITOR NAI INC. 2016-10-13 US disclosed
US-20160296494-A1 DIHYDROOROTIC AND ACID DEHYDROGENASE INHIBITOR NAI INC. 2016-10-13 US disclosed
US-9440913-B2 Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient NAI INC. (JP) 2016-09-13 US disclosed
US-9440913-B2 Dihydroxybenzene derivatives and antiprotozoal agent comprising same as active ingredient NAI INC. (JP) 2016-09-13 US disclosed
US-20150166498-A1 DIHYDROOROTIC ACID DEHYDROGENASE INHIBITOR NAI INC. (JP) 2015-06-18 US disclosed
US-20150166498-A1 DIHYDROOROTIC ACID DEHYDROGENASE INHIBITOR NAI INC. (JP) 2015-06-18 US disclosed
EP-2857010-A1 DIHYDROOROTIC ACID DEHYDROGENASE INHIBITOR NAI Inc. (JP) 2015-04-08 EP disclosed
US-20130296422-A1 Novel Dihydroxybenzene Derivatives and Antiprotozoal Agent Comprising Same as Active Ingredient ARIGEN PHARMACEUTICALS, INC. (JP) 2013-11-07 US disclosed
US-4484000-A PHOTOGRAPHIC STABILIZERS CIBA-GEIGY AG (CH) 1984-11-20 US disclosed
EP-0069068-B1 HYDROQUINONES AND THEIR PREPARATION CIBA-GEIGY AG (CH) 1984-10-10 EP disclosed
US-4466969-A 7-Oxoprostacyclin derivatives and their use as hypotensives and bronchodilators SCHERING AKTIENGESELLSCHAFT (DE) 1984-08-21 US disclosed
EP-0106799-A1 Phenols and their preparation CIBA-GEIGY AG (CH) 1984-04-25 EP disclosed
US-4430425-A HYDROQUINONE DERIVATIVES CIBA-GEIGY AG (CH) 1984-02-07 US disclosed
EP-0069070-A1 Colour photographic materials containing stabilizers CIBA-GEIGY AG (CH) 1983-01-05 EP disclosed
US-4359467-A Prostanoic acid derivatives and their preparation SCHERING AKTIENGESELLSCHAFT (DE) 1982-11-16 US disclosed
EP-0059756-A1 7-OXOPROSTACYCLIN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF. SCHERING AG (DE) 1982-09-15 EP disclosed
WO-1982001002-A1 7-OXOPROSTACYCLIN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF NICKOLSON R 1982-04-01 WO disclosed
US-4284646-A Prostanoic acid derivatives and their preparation SCHERING AKTIENGESELLSCHAFT (DE) 1981-08-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150166498-A1 DIHYDROOROTIC ACID DEHYDROGENASE INHIBITOR DHODH, DPYD, DLD ALDH1A1 93/4885LMNA 4866/4885HSD17B10 38/4885
US-20130296422-A1 Novel Dihydroxybenzene Derivatives and Antiprotozoal Agent Comprising Same as Active Ingredient CBR3, CBR1, DHX35 ALDH1A1 1072/4885LMNA 3363/4885HSD17B10 423/4885
US-20160296494-A1 DIHYDROOROTIC AND ACID DEHYDROGENASE INHIBITOR DHODH, DPYD, DLD ALDH1A1 75/4885LMNA 4867/4885HSD17B10 38/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.